LENZ

LENZ Therapeutics

58 hedge funds and large institutions have $432M invested in LENZ Therapeutics in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

27% less capital invested

Capital invested by funds: $587M → $432M (-$156M)

Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$8.56M
2 +$5.22M
3 +$3.54M
4
BlackRock
BlackRock
New York
+$3.26M
5
SFM
Sphera Funds Management
Israel
+$1.64M

Top Sellers

1 -$15.2M
2 -$14.9M
3 -$9.94M
4
Millennium Management
Millennium Management
New York
-$5.15M
5
Jennison Associates
Jennison Associates
New York
-$4.86M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$2.06M
27
$1.57M
28
$897K
29
$824K
30
$569K
31
$530K
32
$520K
33
$374K
34
$247K
35
$240K
36
$197K
37
$179K
38
$167K
39
$160K
40
$147K
41
$145K
42
$141K
43
$123K
44
$109K
45
$107K
46
$98K
47
$83K
48
$74K
49
$73K
50
$72K